Literature DB >> 7916226

Use of CD4 lymphocyte count to predict long-term survival free of AIDS after HIV infection.

A N Phillips1, C A Sabin, J Elford, M Bofill, G Janossy, C A Lee.   

Abstract

OBJECTIVE: To estimate the probability of remaining free of AIDS for up to 25 years after infection with HIV by extrapolation of changes in CD4 lymphocyte count.
DESIGN: Cohort study of subjects followed from time of HIV seroconversion until 1 January 1993. Creation of model by using extrapolated linear regression slopes of CD4 count to predict development of AIDS after 1993.
SETTING: Regional haemophilia centre in teaching hospital.
SUBJECTS: 111 men with haemophilia infected with HIV during 1979-85. Median length of follow up 10.1 years, median number of CD4 counts 17. The model was not fitted for three men because only one CD4 measurement was available. MAIN OUTCOME MEASURES: Development of AIDS.
INTERVENTIONS: From 1989 prophylaxis against candida and Pneumocystis carinii pneumonia and antiretroviral drugs when CD4 count fell below 200 x 10(6)/l.
RESULTS: 44 men developed AIDS up to 1 January 1993. When AIDS was defined as a CD4 count of 50 x 10(6)/l the model predicted that 25% (95% confidence interval 16% to 34%) would survive for 20 years after seroconversion and 18% (11% to 25%) for 25 years. Changing the CD4 count at which AIDS was assumed to occur did not alter the results. Younger patients had a higher chance of 20 year survival than older patients (32% (12% to 52%) for those aged < 15, 26% (14% to 38%) for those aged 15-29, and 15% (0% to 31%) for those aged > or = 30).
CONCLUSIONS: These results suggest that even with currently available treatment up to a quarter of patients with HIV infection will survive for 20 years after seroconversion without developing AIDS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7916226      PMCID: PMC2540903          DOI: 10.1136/bmj.309.6950.309

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  29 in total

1.  Course of HIV-I infection in a cohort of homosexual and bisexual men: an 11 year follow up study.

Authors:  G W Rutherford; A R Lifson; N A Hessol; W W Darrow; P M O'Malley; S P Buchbinder; J L Barnhart; T W Bodecker; L Cannon; L S Doll
Journal:  BMJ       Date:  1990-11-24

2.  Prediction of progression to AIDS by analysis of CD4 lymphocyte counts in a haemophilic cohort.

Authors:  A Phillips; C A Lee; J Elford; G Janossy; M Bofill; A Timms; P B Kernoff
Journal:  AIDS       Date:  1989-11       Impact factor: 4.177

3.  Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS.

Authors:  W Lang; H Perkins; R E Anderson; R Royce; N Jewell; W Winkelstein
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1989

4.  The progression of HIV disease in a haemophilic cohort followed for 12 years.

Authors:  C Sabin; A Phillips; J Elford; P Griffiths; G Janossay; C Lee
Journal:  Br J Haematol       Date:  1993-02       Impact factor: 6.998

5.  Progression to AIDS and predictors of AIDS in seroprevalent and seroincident cohorts of homosexual men.

Authors:  M T Schechter; K J Craib; T N Le; B Willoughby; B Douglas; P Sestak; J S Montaner; M S Weaver; K D Elmslie; M V O'Shaughnessy
Journal:  AIDS       Date:  1989-06       Impact factor: 4.177

6.  Serial CD4 lymphocyte counts and development of AIDS.

Authors:  A N Phillips; C A Lee; J Elford; G Janossy; A Timms; M Bofill; P B Kernoff
Journal:  Lancet       Date:  1991-02-16       Impact factor: 79.321

7.  Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome.

Authors:  H C Lane; H Masur; E P Gelmann; D L Longo; R G Steis; T Chused; G Whalen; L C Edgar; A S Fauci
Journal:  Am J Med       Date:  1985-03       Impact factor: 4.965

8.  Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort.

Authors:  A R Moss; P Bacchetti; D Osmond; W Krampf; R E Chaisson; D Stites; J Wilber; J P Allain; J Carlson
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-12

9.  The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.

Authors:  J L Fahey; J M Taylor; R Detels; B Hofmann; R Melmed; P Nishanian; J V Giorgi
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245

10.  Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?

Authors:  V Beral; T A Peterman; R L Berkelman; H W Jaffe
Journal:  Lancet       Date:  1990-01-20       Impact factor: 79.321

View more
  16 in total

1.  Population-based hematologic and immunologic reference values for a healthy Ugandan population.

Authors:  Eric S Lugada; Jonathan Mermin; Frank Kaharuza; Elling Ulvestad; Willy Were; Nina Langeland; Birgitta Asjo; Sam Malamba; Robert Downing
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

Review 2.  Can we predict the prognosis of HIV infection? How to use the findings of a prospective study.

Authors:  N Low; M Egger
Journal:  Sex Transm Infect       Date:  1998-04       Impact factor: 3.519

3.  Liver transplantation for haemophiliacs with hepatitis C cirrhosis.

Authors:  M McCarthy; E Gane; S Pereira; C J Tibbs; N Heaton; M Rela; H Hambley; R Williams
Journal:  Gut       Date:  1996-12       Impact factor: 23.059

4.  Limitation of inverse probability-of-censoring weights in estimating survival in the presence of strong selection bias.

Authors:  Chanelle J Howe; Stephen R Cole; Joan S Chmiel; Alvaro Muñoz
Journal:  Am J Epidemiol       Date:  2011-02-02       Impact factor: 4.897

5.  The UK register of HIV seroconverters: methods and analytical issues. UK register of HIV seroconverters (UKRHS) Steering Committee.

Authors: 
Journal:  Epidemiol Infect       Date:  1996-10       Impact factor: 2.451

Review 6.  Will we ever know when to treat HIV infection?

Authors:  A N Phillips; G D Smith; M A Johnson
Journal:  BMJ       Date:  1996-09-07

7.  Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users.

Authors:  V Soriano; J García-Samaniego; E Valencia; R Rodríguez-Rosado; F Muñoz; J González-Lahoz
Journal:  Eur J Epidemiol       Date:  1999-01       Impact factor: 8.082

8.  Laboratory Accuracy Improvement in the UK NEQAS Leucocyte Immunophenotyping Immune Monitoring Program: An Eleven-Year Review via Longitudinal Mixed Effects Modeling.

Authors:  John Bainbridge; Wes Rountree; Raul Louzao; John Wong; Liam Whitby; Thomas N Denny; David Barnett
Journal:  Cytometry B Clin Cytom       Date:  2017-05-16       Impact factor: 3.058

Review 9.  AIDS and the lung: update 1995. 2. New developments in the pulmonary diseases affecting HIV infected individuals.

Authors:  D M Mitchell; R F Miller
Journal:  Thorax       Date:  1995-03       Impact factor: 9.139

10.  The effect of CMV infection on progression of human immunodeficiency virus disease is a cohort of haemophilic men followed for up to 13 years from seroconversion.

Authors:  C A Sabin; A N Phillips; C A Lee; G Janossy; V Emery; P D Griffiths
Journal:  Epidemiol Infect       Date:  1995-04       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.